These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38117108)

  • 1. [Psychedelic-assisted psychotherapy in palliative medicine].
    Schaller A; Bourquin G; Amorim Araujo I; Ljuslin M
    Rev Med Suisse; 2023 Dec; 19(855):2395-2398. PubMed ID: 38117108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
    Schimmers N; Breeksema JJ; Smith-Apeldoorn SY; Veraart J; van den Brink W; Schoevers RA
    Psychopharmacology (Berl); 2022 Jan; 239(1):15-33. PubMed ID: 34812901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.
    Miceli McMillan R; Jordens C
    Med Health Care Philos; 2022 Jun; 25(2):225-237. PubMed ID: 35064398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 9. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.
    Rosa WE; Sager Z; Miller M; Bernstein I; Doerner Rinaldi A; Addicott K; Ljuslin M; Adrian C; Back AL; Beachy J; Bossis AP; Breitbart WS; Cosimano MP; Fischer SM; Guss J; Knighton E; Phelps J; Richards BD; Richards WA; Tulsky JA; Williams MT; Beaussant Y
    J Palliat Med; 2022 Aug; 25(8):1273-1281. PubMed ID: 35285721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychedelics for existential distress in terminally ill patients].
    Schimmel N; Breeksema JJ; Veraart JKE; van den Brink W; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):659-668. PubMed ID: 32816294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care.
    Nigam K; Curseen KA; Beaussant Y
    Clin Geriatr Med; 2023 Aug; 39(3):423-436. PubMed ID: 37385694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
    Gold ND; Mallard AJ; Hermann JC; Zeifman RJ; Pagni BA; Bogenschutz MP; Ross S
    J Palliat Med; 2023 Oct; 26(10):1408-1418. PubMed ID: 37167080
    [No Abstract]   [Full Text] [Related]  

  • 13. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Care Practices with Psychedelics - A Qualitative Study of Users' Perspectives.
    Soares CM; Leite Â; Pinto M
    J Psychoactive Drugs; 2023; 55(2):159-169. PubMed ID: 35574941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
    Agin-Liebes GI; Malone T; Yalch MM; Mennenga SE; Ponté KL; Guss J; Bossis AP; Grigsby J; Fischer S; Ross S
    J Psychopharmacol; 2020 Feb; 34(2):155-166. PubMed ID: 31916890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B; Luoma JB; Bathje GJ; Rhea J; Narloch VF
    Harm Reduct J; 2021 Apr; 18(1):40. PubMed ID: 33827588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.
    Fogg C; Michaels TI; de la Salle S; Jahn ZW; Williams MT
    Exp Clin Psychopharmacol; 2021 Oct; 29(5):539-554. PubMed ID: 34096755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.